Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

Hervé Avet-Loiseau, Rafael Fonseca, David Siegel, Meletios A. Dimopoulos, Ivan Špička, Tamás Masszi, Roman Hájek, Laura Rosiñol, Vesselina Goranova-Marinova, Georgi Mihaylov, Vladimír Maisnar, Maria Victoria Mateos, Michael Wang, Ruben Niesvizky, Albert Oriol, Andrzej Jakubowiak, Jiri Minarik, Antonio Palumbo, William Bensinger, Vishal KukretiDina Ben-Yehuda, A. Keith Stewart, Mihaela Obreja, Philippe Moreau

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds